Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
40 Leser
Artikel bewerten:
(0)

Enteric Disease Testing Market Driven by Growing Prevalence of Bacterial & Parasitic Diseases, Says TMR

ALBANY, New York, September 4, 2017 /PRNewswire/ --

The key players operating in the enteric disease testing market are Trinity Biotech plc, Biomerica, Inc., Bio-Rad Laboratories, Inc., Alere Inc., Biomerieux SA, Meridian Bioscience Inc., CorisBioconcept SPRL, Quest Diagnostics Incorporated, Cepheid Inc., and DiaSorin. The global enteric disease testing market is fragmented due to the presence of many small-scale vendors operating in regional markets. However, the global market is dominated by a few major players operating globally. Mergers and acquisitions in order to expand the geographical footprint are likely to remain a popular competitive tactic for players in the global enteric disease testing market in the coming years.

According to Transparency Market Research, the global enteric disease testing market was valued at US$3.7 bn in 2017 and is likely to rise to more than US$4.9 bn by 2025. The market is expected to exhibit a steady 3.6% CAGR therein.

Browse Market Research Report @ http://www.transparencymarketresearch.com/enteric-disease-testing-market.html

Geographically, the global enteric disease testing market is dominated by North America and Europe, which collectively accounted for a majority share in the market in 2017. The Europe market is likely to retain the lead in enteric disease testing in the coming years, with North America following closely behind. Despite the slow expected CAGR of the Asia Pacific enteric disease testing market, the region could witness significant growth of the market due to the high population in the region and the vast unmet demand for medical facilities. By pathogen type, bacterial infections led to significant demand from the global enteric disease testing market and are likely to remain the key segment in the forecast period.

Rising Availability of Advanced Testing Drives Enteric Disease Testing Market in Developed Countries

Enteric disease testing has undergone steady advancement in the last few years due to steady adoption of technological advancements, particularly in developed countries. Enteric diseases represent a growing health threat due to their growing prevalence and the increasing healthcare expenditure necessitated by the same.

The diverse array of pathogens responsible for numerous enteric diseases have been studied in detail in recent years due to the growing availability of microscopic examination facilities. Molecular diagnostic testing has become a key part of the enteric disease testing market in recent years and is likely to remain a strong contributor. The strong pharmaceuticals industry in developed regions such as North America and Europe has thus aided the enteric disease testing market in developed countries and is likely to remain a key driver for the market in the coming years.

Traveling to relatively underdeveloped regions such as Central and South America, Africa, and Southeast Asia has become a major trend in developed regions. This has also contributed to the rising prevalence of enteric diseases in North America and Europe, as developing countries tend to lack the hygiene standards observed in developed regions. The growing support to the tourism sector in these countries is likely to boost the number of tourists from developed regions, which is likely to drive the global enteric disease testing market in the coming years.

Fill the form for an exclusive sample of this report @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258

Vast Scope in Asia Pacific Market Undercut by Lack of Infrastructure

The lack of medical research infrastructure in populous developing regions such as Asia Pacific has held the enteric disease testing market back. The high prevalence of enteric diseases in highly populous economies such as China and India is likely to drive the market at a steady rate in the coming years, but Asia Pacific is likely to lag behind developed Western markets due to the lack of awareness about various enteric diseases and the consequent lack of healthcare infrastructure.

The information in this preview comes from a Transparency Market Research report titled 'Enteric Disease Testing Market (Disease Indication: Bacterial Enteric Disease, Viral Enteric Disease, Parasitic Enteric Disease; Testing Methods: Immunoassay Testing, Conventional Testing, Molecular Diagnostic Testing; End Users: Hospitals, Diagnostic Laboratories, Physician Offices) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2017 - 2025.'

The global Enteric Disease Testing Market is segmented as follows:

Global Enteric Disease Testing Market, by Disease Indication

  • Bacterial Enteric Disease
    • C.difficile Infection
    • Campylobacteriosis
    • Cholera
    • E.coli Infection
    • H.pylori Infection
    • Salmonellosis
    • Shigellosis
  • Viral Enteric Disease
    • Rotavirus Infection
    • Norovirus Infection
  • Parasitic Enteric Disease
    • Amebiasis
    • Cryptosporidiosis
    • Giardiasis

Global Enteric Disease Testing Market, by Testing Methods

  • Immunoassay Testing
  • Conventional Testing
  • Molecular Diagnostic Testing

Global Enteric Disease Testing Market, by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Physician Offices

Global Enteric Disease Testing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Browse Related Research Report:

Molecular Diagnostics Market (Technology - PCR and Real-Time PCR, Hybridization, Microarray, Transcription-mediated Amplification, and Next-Generation Sequencing; Application - Infectious Diseases, Oncology, Blood Screening, Microbiology, Genetic Testing, and Women's Health; End User: Hospitals, Diagnostic Laboratories, Blood Banks, Academics, and Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025

http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html

Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2026

http://www.transparencymarketresearch.com/immunoassay-market.html

Infectious Disease Molecular Diagnostics Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

http://www.transparencymarketresearch.com/infectious-disease-testing-instrumentation.html

About Us:

Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.


Contact Us:

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

Blog:https://theglobalhealthnews.com/

http://www.editiontruth.com/


Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2017 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.